Manning & Napier Advisors LLC Vertex Pharmaceuticals Inc Transaction History
Manning & Napier Advisors LLC
- $8.76 Trillion
- Q4 2024
A detailed history of Manning & Napier Advisors LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Manning & Napier Advisors LLC holds 150,126 shares of VRTX stock, worth $73.3 Million. This represents 0.69% of its overall portfolio holdings.
Number of Shares
150,126
Previous 155,761
3.62%
Holding current value
$73.3 Million
Previous $72.4 Billion
16.55%
% of portfolio
0.69%
Previous 0.8%
Shares
3 transactions
Others Institutions Holding VRTX
# of Institutions
1,712Shares Held
222MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$13.1 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$11.3 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.4 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.77 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$4.4 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $125B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...